# Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

> **NCT04448145** · — · RECRUITING · sponsor: **Columbia University** · enrollment: 800 (estimated)

## Conditions studied

- COVID-19
- Corona Virus Infection
- SARS-CoV 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04448145
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-26
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2025-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04448145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04448145, "Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04448145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*